Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 050446/0233 | |
| Pages: | 7 |
| | Recorded: | 09/20/2019 | | |
| Attorney Dkt #: | 009790.013WO1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/07/2023
|
Application #:
|
16496286
|
Filing Dt:
|
09/20/2019
|
|
Publication #:
|
|
Pub Dt:
|
06/17/2021
| | |
PCT #:
|
US2018022414
|
|
Title:
|
TREATMENT OF CANCER WITH A SEMAPHORIN-4D ANTIBODY IN COMBINATION WITH AN EPIGENETIC MODULATING AGENT
|
|
|
Assignee
|
|
|
|
|
| 1895 MT. HOPE AVENUE |
| ROCHESTER, NEW YORK 14620 |
|
|
Correspondence name and address
|
| |
CANADY + LORTZ LLP
|
| |
3701 WILSHIRE BLVD
|
| |
SUITE 508
|
| |
LOS ANGELES, CA 90010
|
Search Results as of:
09/24/2024 05:55 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
